专题笔谈

体质量管理在糖尿病防治中的利与弊

  • 鲁可 ,
  • 陈小燕
展开
  • 广州医科大学附属第一医院 (广州 510145 )
陈小燕,医学博士,教授/三级主任医师,硕士研究生导师。广州医科大学附属第一医院内分泌科科主任,学术带头人,广东省保健协会糖尿病分会主任委员、广州市医学会内分泌分会副主任委员、中国民族卫生协会糖尿病分会常委、广东省医学会内分泌分学会常委。南山学院内分泌系统模块教研室负责人;岭南名医、第三届“羊城好医生”。从事内分泌代谢疾病领域临床、教学及科研工作30余年,主要研究领域为肥胖及糖尿病的发病机制及早期干预;先后参与“十五”国家科技攻关计划课题2项,承担及负责国家级、省部级科研项目多项;发表及参与发表学术论文90余篇。

收稿日期: 2024-03-26

  网络出版日期: 2024-08-26

Pros and cons of weight management in the prevention and treatment of diabetes mellitus

  • Ke LU ,
  • Xiaoyan. CHEN
Expand
  • The First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510145,China

Received date: 2024-03-26

  Online published: 2024-08-26

摘要

随着人民生活水平的提高及生活方式的改变,我国肥胖及糖尿病人群数量不断激增,造成了极大的疾病负担。近年来,循证证据越来越强调体质量管理在糖尿病防治中的重要地位。尽管在理论和实践层面有诸多问题有待进一步阐明,但新形势下迫切需要医患双方转变思维方式。减重是一把“双刃剑”,让伴有超重或肥胖的糖尿病患者获益最大化的减重策略应建立在正确理解体质量管理内涵的基础上。长期维持减重成效仍面临许多的挑战,需要准确评估病情,权衡减重利弊,实施合理可行的减重方案,坚持长期的专业化管理。

本文引用格式

鲁可 , 陈小燕 . 体质量管理在糖尿病防治中的利与弊[J]. 实用医学杂志, 2024 , 40(16) : 2219 -2223 . DOI: 10.3969/j.issn.1006-5725.2024.16.004

Abstract

With the improvement of people's living standards, the number of patients with obesity and diabetes in China has been surging, causing a great disease burden. In recent years, evidence-based guidelines has increasingly emphasized the importance of weight management in the prevention and treatment of diabetes. Although there are many issues in theoretical and practical levels to be further elucidated, there is an urgent need for both doctors and patients to adapt to this new situation. Weight loss is a “double-edged sword”. Weight loss strategies that maximize the benefits for diabetic patients with overweight or obesity should be based on a proper understanding of the meaning of weight management. Long-term maintenance of weight loss still faces many challenges, which require accurate assessment of the disease, weighing the pros and cons of weight loss, implementation of a reasonable and feasible weight loss program, and adherence to long-term professional management.

参考文献

1 CHEN K, SHEN Z, GU W, et al. Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults [J]. Diabetes Obes Metab, 2023, 25(11): 3390-3399. doi:10.1111/dom.15238
2 WANG Y, LIANG X, ZHOU Z, et al. Prevalence and Numbers of Diabetes Patients with Elevated BMI in China: Evidence from a Nationally Representative Cross-Sectional Study [J]. Int J Environ Res Public Health, 2022, 19(5):2989. doi:10.3390/ijerph19052989
3 DAVIES M J, ARODA V R, COLLINS B S, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [J]. Diabetes Care, 2022, 45(11): 2753-2786. doi:10.2337/dci22-0034
4 LINGVAY I, SUMITHRAN P, COHEN R V, et al. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation [J]. Lancet, 2022, 399(10322): 394-405. doi:10.1016/s0140-6736(21)01919-x
5 DWIVEDI A K, DUBEY P, CISTOLA D P, et al. Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies [J]. Curr Cardiol Rep, 2020, 22(4): 25. doi:10.1007/s11886-020-1273-y
6 KNOWLER W C, BARRETT-CONNOR E, FOWLER S E, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002, 346(6): 393-403. doi:10.1056/nejmoa012512
7 LEAN M E, LESLIE W S, BARNES A C, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial [J]. Lancet, 2018, 391(10120): 541-551. doi:10.1016/s0140-6736(17)33102-1
8 李东玲, 陈小燕, 黄炯强, 等. 肥胖及超重2型糖尿病患者代谢手术后5年疗效随访研究 [J]. 中国糖尿病杂志, 2022, 30(2): 101-105.
9 POLEMITI E, BAUDRY J, KUXHAUS O, et al. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study [J]. Diabetologia, 2021, 64(4): 814-825. doi:10.1007/s00125-020-05362-7
10 AMINIAN A, ALEASSA E M, BHATT D L, et al. Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: A nationwide study [J]. Diabetes Obes Metab, 2019, 21(9): 2058-2067. doi:10.1111/dom.13765
11 WING R R, BOLIN P, BRANCATI F L, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes [J]. N Engl J Med, 2013, 369(2): 145-154. doi:10.1056/nejmoa1212914
12 SCHIAVON C A, CAVALCANTI A B, OLIVEIRA J D, et al. Randomized Trial of Effect of Bariatric Surgery on Blood Pressure After 5 Years [J]. J Am Coll Cardiol, 2024, 83(6): 637-648. doi:10.1016/j.jacc.2023.11.032
13 FATLY M AL, MULDER M T, ROETERS VAN LENNEP J, et al. The effect of diet-induced weight loss on circulating homocysteine levels in people with obesity and type 2 diabetes [J]. Nutr J, 2024, 23(1): 2. doi:10.1186/s12937-023-00908-y
14 GAMBINO F, ZAMMUTO M M, VIRZì A, et al. Treatment options in obstructive sleep apnea [J]. Intern Emerg Med, 2022, 17(4): 971-978. doi:10.1007/s11739-022-02983-1
15 PANDEY A, PATEL K V, BAHNSON J L, et al. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial [J]. Circulation, 2020, 141(16): 1295-1306. doi:10.1161/circulationaha.119.044865
16 ABBASIHORMOZI S, KOUHKAN A, SHAHVERDI A, et al. How much obesity and diabetes do impair male fertility? [J]. Reprod Biol Endocrinol, 2023, 21(1): 48. doi:10.1186/s12958-022-01034-w
17 李东玲, 陈小燕, 黄炯强, 等. 胃束带及折叠术后短期妊娠及围产期处理个案报道并文献复习 [J]. 广州医科大学学报, 2015, 25(5): 80-84.
18 SAUTER E R. Obesity, metabolic and bariatric surgery, and cancer prevention: what do we need to learn and how do we get there? [J]. Surg Obes Relat Dis, 2023, 19(7): 781-787. doi:10.1016/j.soard.2023.01.029
19 GONZáLEZ-SáNCHEZ D L, MURILLO-PRADO B R, ZARAGOZA-CALDERóN C M, et al. Micronutrient Deficiency Pre- and Post-bariatric Metabolic Surgery in Latin America: a Systematic Review [J]. Obes Surg, 2023, 33(2): 635-664. doi:10.1007/s11695-022-06424-y
20 LEE H G, LU Y A, JE J G, et al. Effects of Ethanol Extracts from Grateloupia elliptica, a Red Seaweed, and Its Chlorophyll Derivative on 3T3-L1 Adipocytes: Suppression of Lipid Accumulation through Downregulation of Adipogenic Protein Expression [J]. Mar Drugs, 2021, 19(2): 91. doi:10.3390/md19020091
21 LIU L, CHEN J, WANG L, et al. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database [J]. Front Endocrinol (Lausanne), 2022, 13: 1043789. doi:10.3389/fendo.2022.1043789
22 DANKNER R, MURAD H, AGAY N, et al. Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes [J]. JAMA, 2024, 7(1): e2350408. doi:10.1001/jamanetworkopen.2023.50408
23 JAKOBSEN G S, SM?STUEN M C, SANDBU R, et al. Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities [J]. JAMA, 2018, 319(3): 291-301. doi:10.1001/jama.2017.21055
24 MESINOVIC J, JANSONS P, ZENGIN A, et al. Exercise attenuates bone mineral density loss during diet-induced weight loss in adults with overweight and obesity: A systematic review and meta-analysis [J]. J Sport Health Sci, 2021, 10(5):550-559. doi:10.1016/j.jshs.2021.05.001
25 BIEHL A, VEN?L?INEN M S, SUOJANEN L U, et al. Development and validation of a weight-loss predictor to assist weight loss management [J]. Sci Rep, 2023, 13(1): 20661. doi:10.1038/s41598-023-47930-y
26 MONACO-FERREIRA D V, LEANDRO-MERHI V A. Weight Regain 10 Years After Roux-en-Y Gastric Bypass [J]. Obes Surg, 2017, 27(5): 1137-1144. doi:10.1007/s11695-016-2426-3
27 SCHMITZ J, EVERS N, AWAZAWA M, et al. Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss [J]. Mol Metab, 2016, 5(5): 328-339. doi:10.1016/j.molmet.2015.12.001
28 CAMPOS J M, LINS D C, SILVA L B, et al. Metabolic surgery, weight regain and diabetes re-emergence [J]. Arq Bras Cir Dig, 2013, 26(): 57-62. doi:10.1590/s0102-67202013000600013
29 KUSHNER R F, RYAN D H. Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews [J]. JAMA, 2014, 312(9): 943-952. doi:10.1001/jama.2014.10432
30 ELMALEH-SACHS A, SCHWARTZ J L, BRAMANTE C T, et al. Obesity Management in Adults: A Review [J]. JAMA, 2023, 330(20): 2000-2015. doi:10.1001/jama.2023.19897
31 GE L, SADEGHIRAD B, BALL G D C, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials [J]. BMJ, 2020, 369: m696. doi:10.1136/bmj.m3095
32 ISTFAN N W, LIPARTIA M, ANDERSON W A, et al. Approach to the Patient: Management of the Post-Bariatric Surgery Patient With Weight Regain [J]. J Clin Endocrinol Metab, 2021, 106(1): 251-263. doi:10.1210/clinem/dgaa702
33 ROSENBAUM M, FOSTER G. Differential mechanisms affecting weight loss and weight loss maintenance [J]. Nat Metab, 2023, 5(8): 1266-1274. doi:10.1038/s42255-023-00864-1
文章导航

/